When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALT - Altimmune: Several Catalysts In 2 Large Market Indications This Year
Altimmune Inc.
Results from phase 1b NAFLD study using pemvidutide are to be released 2nd half of 2022;Q3 of 2022 will be 12-week data and Q4 of 2022 will be 24-week data.
It is estimated that the global NASH market could be worth $20 billion by 2027.
Interim results from the phase 2 MOMENTUM study using pemvidutide for obesity are expected in Q4 of 2022; This will deal with 24-week interim data for weight loss.
The global obesity treatment market will reach $15.6 billion by 2024.